EntryPoint Capital’s CryoPort CYRX Stock Holding History

EntryPoint Capital’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,061	Closed	-$86.1K	–	736
2024 Q4	$86.1K	Sell	11,061 -10,122	-48%	-$75.5K	0.04%	675
2024 Q3	$172K	Buy	+21,183	New	+$173K	0.1%	502

Other funds holding CYRX

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

TAM

Thematics Asset Management Paris, France $2.2B AUM 18.17% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

EntryPoint Capital's CYRX Position: Q1 2025 in Review

EntryPoint Capital sold out of CryoPort (CYRX) in Q1 2025, closing a stake of 11,061 shares — an estimated $86.1K sold.

EntryPoint Capital first reported a position in CYRX in Q3 2024 and held it in 2 quarters. The position peaked at $172K in Q3 2024. 153 funds tracked by Wall St. Rank hold CYRX as of Q1 2025.

EntryPoint Capital reported no remaining CryoPort position as of Q1 2025 after selling out during the quarter.
EntryPoint Capital sold 11,061 CryoPort shares in Q1 2025, an estimated $86.1K.
EntryPoint Capital first reported a position in CryoPort in Q3 2024 and held it in 2 quarters.
EntryPoint Capital's CryoPort position peaked at $172K in Q3 2024.
153 funds tracked by Wall St. Rank held CryoPort as of Q1 2025.

Based on EntryPoint Capital's 13F filing for Q1 2025, filed 14 May 2025.